|
Back to Home » April 2022 News » Oral Cancer Therapeutics Market - 51% of Growth to Originate from North America | Driven by Increasing Incidence & Prevalence of Oral Cancer| Technavio |
Oral Cancer Therapeutics Market - 51% of Growth to Originate from North America | Driven by Increasing Incidence & Prevalence of Oral Cancer| Technavio |
April 05, 2022
NEW YORK, April 5, 2022 /PRNewswire/ -- The Oral Cancer Therapeutics Market offers a comprehensive analysis of new product launches, the latest trends, drivers, and challenges. The oral cancer therapeutics market value is set to grow by USD 1.14 billion from 2021 to 2026. However, the...
Source URL: https://www.prnewswire.com:443/news-releases/oral-cancer-therapeutics-market---51-of-growth-to-originate-from-north-america--driven-by-increasing-incidence--prevalence-of-oral-cancer-technavio-301516828.html
|
|
|
|
